6505--Acyclovir Capsules (VA-25-00048078)
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0033
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Department Of Veterans Affairs Opal/National Acquisition Center Hines IL 60141
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs National Acquisition Center is seeking to procure Acyclovir 200MG Capsules through a competitive solicitation. The procurement involves two line items: one for 100 capsules per bottle and another for 500 capsules per bottle, with an annual requirement of 3,256 and 15,475 bottles respectively. Potential offerors must submit pricing for both line items covering a base year and four option years, with the contract to be awarded in aggregate. The solicitation requires submission of National Drug Code (NDC) and Abbreviated New Drug Application (ANDA) numbers, and pricing must be provided to two decimal places. The response deadline is May 1, 2025, with the place of performance located at the VA OPAL/National Acquisition Center Building 37 in Hines, Illinois.
The procurement is classified under NAICS Code 325412 for Pharmaceutical Preparation Manufacturing and Product Service Code 6505 for Drugs and Biologicals. No specific set-aside designations are indicated for this opportunity, suggesting it is open to all qualified pharmaceutical manufacturers. While specific award values are not disclosed, the annual procurement volumes suggest a significant multi-year contract potential. The solicitation covers a total five-year period, including the base year and four option years, with consistent annual bottle quantities for both line items. Interested vendors should note the detailed requirements and prepare comprehensive proposals that meet the Department of Veterans Affairs' specifications for Acyclovir Capsules.
Notice text
Continuation of SF-1449, Block 3:
The following information shall be entered by the Contracting Officer at the time of contract award according to the timeframes specified in this solicitation s Section B, Scope of Contract, Section 1.4 Contract Effective Date, Implementation Period, and Ordering Period.
Contract Award/Effective Date: ___________________
Implementation Period: __________________________
Ordering Period (Base Year): _____________________
Offerors shall not enter information into the above fields.
Continuation of SF-1449, Blocks 19 through 24:
To be considered for award, offerors must submit a price for line items 1 and 2 for the base year and all four option years. One award will be made in the aggregate for line items 1 and 2 for the base year and all four option years. Offered prices shall not exceed two decimal places.
Note: NDC is defined as National Drug Code. ANDA is defined as Abbreviated New Drug Application
Line Item 1
Acyclovir 200MG Capsules, 100 Capsules per Bottle
NDC # __________________
ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
3,256
Bottles
Option Year One
3,256
Bottles
Option Year Two
3,256
Bottles
Option Year Three
3,256
Bottles
Option Year Four
3,256
Bottles
Line Item 2
Acyclovir 200MG Capsules, 500 Capsules per Bottle
NDC # __________________
ANDA#_________________
Schedule of Supplies
Quantity
Unit
Unit Price
Amount (Unit Price x Quantity)
Base Year
15,475
Bottles
Option Year One
15,475
Bottles
Option Year Two
15,475
Bottles
Option Year Three
15,475
Bottles
Option Year Four
15,475
Bottles
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0033_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Acyclovir Capsules | Award Notice | |
| 6505--Acyclovir Capsules (VA-25-00048078) | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sacubitril/Valsartan Tablets (VA-27-00014055) | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity